Citadel Advisors - INTELLIPHARMACEUTICS INTL IN ownership

INTELLIPHARMACEUTICS INTL IN's ticker is IPCI and the CUSIP is 458173101. A total of 22 filers reported holding INTELLIPHARMACEUTICS INTL IN in Q3 2016. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of INTELLIPHARMACEUTICS INTL IN
ValueSharesWeighting
Q2 2018$8,000
+33.3%
18,400
+68.8%
0.00%
Q1 2018$6,000
-70.0%
10,900
-57.4%
0.00%
Q4 2017$20,000
-60.8%
25,562
-50.3%
0.00%
Q3 2017$51,000
+24.4%
51,447
+161.2%
0.00%
Q2 2017$41,000
-54.4%
19,700
-44.7%
0.00%
Q1 2017$90,000
+80.0%
35,600
+104.2%
0.00%
Q4 2016$50,000
+127.3%
17,430
+20.3%
0.00%
Q2 2016$22,00014,4920.00%
Other shareholders
INTELLIPHARMACEUTICS INTL IN shareholders Q3 2016
NameSharesValueWeighting ↓
Atria Investments, Inc 75,895$159,0000.02%
FIRST FOUNDATION ADVISORS 100,900$212,0000.02%
Argent Trust Co 15,121$32,0000.01%
Acrospire Investment Management LLC 1,500$3,0000.00%
Virtu KCG Holdings LLC 33,485$70,0000.00%
SIMPLEX TRADING, LLC 9,846$20,0000.00%
Advisor Group, Inc. 11,791$25,0000.00%
Hudson Bay Capital Management LP 10,000$21,0000.00%
BANK OF AMERICA CORP /DE/ 6$00.00%
WELLS FARGO & COMPANY/MN 1,038$2,0000.00%
View complete list of INTELLIPHARMACEUTICS INTL IN shareholders